Cite
Phospholipid remodeling and its derivatives are associated with COVID-19 severity
MLA
Juntong Wei, et al. “Phospholipid Remodeling and Its Derivatives Are Associated with COVID-19 Severity.” Journal of Allergy and Clinical Immunology, vol. 151, May 2023, pp. 1259–68. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........f3d1cfe0507a8f4220ca3d9375bec3b8&authtype=sso&custid=ns315887.
APA
Juntong Wei, Xiaoyu Liu, Weimin Xiao, Jiahua Lu, Li Guan, Zhangfu Fang, Jiaping Chen, Baoqing Sun, Zongwei Cai, Xizhuo Sun, Hua-Ling Chen, Nanshan Zhong, Zhigang Liu, Jun Yang, Xiaojun Xiao, & Shau-Ku Huang. (2023). Phospholipid remodeling and its derivatives are associated with COVID-19 severity. Journal of Allergy and Clinical Immunology, 151, 1259–1268.
Chicago
Juntong Wei, Xiaoyu Liu, Weimin Xiao, Jiahua Lu, Li Guan, Zhangfu Fang, Jiaping Chen, et al. 2023. “Phospholipid Remodeling and Its Derivatives Are Associated with COVID-19 Severity.” Journal of Allergy and Clinical Immunology 151 (May): 1259–68. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........f3d1cfe0507a8f4220ca3d9375bec3b8&authtype=sso&custid=ns315887.